Willis Johnson & Associates »

Akebia Therapeutics shares owned by Willis Johnson & Associates

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Willis Johnson & Associates from 13F filings

Historical chart of Willis Johnson & Associates investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Willis Johnson & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Willis Johnson & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 18k 1.83
2023-12-31 $22k 18k 1.24
2023-09-30 $20k 18k 1.14

More positions owned by Willis Johnson & Associates

Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr S&p Mc 400gr Etf (IJK)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Ishares Tr Mbs Etf (MBB)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Shrt Nat Mun Etf (SUB)
Vaneck Etf Trust Intrmdt Muni Etf (ITM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Ishares Tr 3 7 Yr Treas Bd (IEI)

View all positions for Willis Johnson & Associates

Top funds holding Akebia Therapeutics

Satter Management
Vanguard Group
Susquehanna International
Millennium Management
Jacobs Levy Equity Management
Federated Investors
Assenagon Asset Management
Connor, Clark & Lunn Investment Management
Citadel Advisors
Citigroup
Bank of America Corporation
Sapient Capital
Two Sigma Investments
Russell Investments
Two Sigma Advisers

View all funds holding Akebia Therapeutics